Orca Bio Wins FDA Approval for TREGZI Cell Therapy
MENLO PARK, Calif., June 30, 2026 Orca Bio announced that the U.S. Food and Drug Administration (FDA) has approved...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
MENLO PARK, Calif., June 30, 2026 Orca Bio announced that the U.S. Food and Drug Administration (FDA) has approved...
HOUSTON, TEXAS, May 04, 2026 Cellenkos has announced that the U.S. Food and Drug Administration (FDA) has granted Investigational...
WILMINGTON, Del., May 1, 2026 Incyte Corporation has secured U.S. Food and Drug Administration (FDA) approval for Jakafi XRâ„¢...
